Clinical Trial Update: A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing semaglutide to placebo in people with type 2 diabetes and peripheral arterial disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2, Peripheral Arterial Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-07-08